The Journal of Dermatology · 1994 · 70 citations · 16 references
MedicineDermatologyPharmacotherapyInflammationOral DiagnosisPediatric DermatologyAnti-inflammatory PharmacologyInflammatory DermatosesInflammatory Oral LesionsInflammatory Skin DiseasesInflammatory Skin DisordersAcne Follow-upAcne PharmacotherapyOil AcneOral Tetracycline TherapyTopical Oral Agents
Twenty patients with nodulocystic acne were randomly allocated to one of two treatment schedules: 1) Tetracycline 500 mg or 2) Tab. Gugulipid (equivalent to 25 mg guggulsterone). Both were taken twice daily for 3 months, and both produced a progressive reduction in the lesions in the majority of patients. With tetracycline, the percentage reduction in the inflammatory lesions was 65.2% as compared to 68% with gugulipid; on comparison, this difference was statistically insignificant (P > 0.05). Follow-up at 3 months showed a relapse in 4 cases on tetracyline and 2 cases on gugulipid. An interesting observation was that the patients with oily faces responded remarkably better to gugulipid.
16
W.J. Cunliffe, Sam Shuster · The Lancet · 1969 · 173 citations
Herbert H. Jones · The Lancet · 1980 · 124 citations